Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions-Reference-Cited by-同舟云学术

Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions

Published:2024-05-02 Issue:7 Volume:25 Page:907-914
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Almusafer Murtadha¹²,Narayan Yash³,Nnorom Ijeoma⁴,Karna Sourabh⁵,Katsouri Antigoni⁶,Russo Giorgio Ivan⁷,Morgado Afonso⁸,Symeonidis Evangelos N⁹,Buchholz Noor¹,Papatsoris Athanasios¹¹⁰^ORCID,Tsampoukas Georgios¹⁴^ORCID

Affiliation:

1. Scientific Office, U-merge Ltd, London, UK

2. Department of Urology, University of Basrah, Basrah, Iraq

3. Medical Doctor, UK

4. Department of Urology, Homerton Healthcare NHS Foundation Trust, Homerton, UK

5. Department of Urology, Milton Keynes University Hospital, Milton Keynes, UK

6. Department of Pharmacy, Princess Alexandra Hospital, Harlow, UK

7. Urology Section, University of Catania, Catania, Italy

8. Serviço de Urologia, Centro Hospitalar Universitário São João, Porto, Portugal

9. Department of Urology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

10. 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2362272

Reference64 articles.

1. Benign prostatic hyperplasia: an overview;Roehrborn CG.;Rev Urol,2005

2. The Prevalence of Nocturnal Polyuria in the United States: Results from the Epidemiology of Nocturnal Polyuria Study

3. BPH: epidemiology and comorbidities;McVary KT.;Am J Manag Care,2006

4. Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK

5. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey